Scythian Biosciences Corp. received approval to list its common shares on the Nasdaq Capital Market.
The company's common shares will trade on Nasdaq under the symbol SCYB, starting Feb. 22.
Scythian Biosciences to list on Nasdaq Capital Market
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Scythian Biosciences Corp. received approval to list its common shares on the Nasdaq Capital Market.
The company's common shares will trade on Nasdaq under the symbol SCYB, starting Feb. 22.